Micrel, Inc. (MCRL) Tops Q3 EPS by 2c; Guides Q4 GAAP EPS
Tweet
Share
E-mailGet Alerts MCRL Hot Sheet
Price: $13.86 --0%
Financial Fact:
Selling, general and administrative: 11.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 11.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Micrel, Inc. (NASDAQ: MCRL) reported Q3 EPS of $0.16, $0.02 better than the analyst estimate of $0.14. Revenue for the quarter came in at $64.2 million versus the consensus estimate of $65.8 million.
Micrel, Inc. sees Q4 2011 GAAP EPS of $0.06-$0.10, which may not compare with the consensus of $0.16.
Micrel, Inc. sees Q4 2011 GAAP EPS of $0.06-$0.10, which may not compare with the consensus of $0.16.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
